Clinical Trials Browser

Completed × Fallopian Tube Neoplasms × Letrozole × Clear all

NCT02283658 2020-10-23

Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Phase 2 Completed

20 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms